ATE145554T1 - Verwendung von kurzkettige fettsäuren enthaltenden lipiden zur aufrechterhaltung der integrität und der funktion des magen-darm-kanals - Google Patents

Verwendung von kurzkettige fettsäuren enthaltenden lipiden zur aufrechterhaltung der integrität und der funktion des magen-darm-kanals

Info

Publication number
ATE145554T1
ATE145554T1 AT91105502T AT91105502T ATE145554T1 AT E145554 T1 ATE145554 T1 AT E145554T1 AT 91105502 T AT91105502 T AT 91105502T AT 91105502 T AT91105502 T AT 91105502T AT E145554 T1 ATE145554 T1 AT E145554T1
Authority
AT
Austria
Prior art keywords
chain fatty
short chain
fatty acids
function
integrity
Prior art date
Application number
AT91105502T
Other languages
English (en)
Inventor
Richard Cotter
Hugh Tucker
Original Assignee
Clintec Nutrition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24016582&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE145554(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Clintec Nutrition Co filed Critical Clintec Nutrition Co
Application granted granted Critical
Publication of ATE145554T1 publication Critical patent/ATE145554T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT91105502T 1990-04-10 1991-04-08 Verwendung von kurzkettige fettsäuren enthaltenden lipiden zur aufrechterhaltung der integrität und der funktion des magen-darm-kanals ATE145554T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50693890A 1990-04-10 1990-04-10

Publications (1)

Publication Number Publication Date
ATE145554T1 true ATE145554T1 (de) 1996-12-15

Family

ID=24016582

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91105502T ATE145554T1 (de) 1990-04-10 1991-04-08 Verwendung von kurzkettige fettsäuren enthaltenden lipiden zur aufrechterhaltung der integrität und der funktion des magen-darm-kanals

Country Status (8)

Country Link
US (1) US5919822A (de)
EP (1) EP0451750B1 (de)
JP (1) JPH05306222A (de)
AT (1) ATE145554T1 (de)
AU (1) AU645070B2 (de)
CA (1) CA2039980A1 (de)
DE (1) DE69123278T2 (de)
ES (1) ES2097162T3 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262555B1 (en) 1998-10-02 2001-07-17 Robicon Corporation Apparatus and method to generate braking torque in an AC drive
AU773195B2 (en) * 1999-07-01 2004-05-20 Commonwealth Scientific And Industrial Research Organisation Nasogastric enteral formulations
AUPQ132599A0 (en) 1999-07-01 1999-07-22 Commonwealth Scientific And Industrial Research Organisation Nasogastric enteral formulations
AUPQ851000A0 (en) * 2000-06-30 2000-07-27 Commonwealth Scientific And Industrial Research Organisation Rapid fatty acid delivery
US6387952B1 (en) * 2000-09-19 2002-05-14 Arco Chemical Technology L.P. Method of treating gastrointestinal disorders, particularly colitis
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
US6864242B2 (en) * 2001-03-05 2005-03-08 Stephen P. Ernest Enteral formulation
ITMI20040187A1 (it) * 2004-02-06 2004-05-06 Cosmo Spa Composizioni farmaceutiche o dietetiche a base di acidi grassi a catena corta e zuccheri complessi per le disfunzioni intestinali
EP1719543A1 (de) * 2005-05-04 2006-11-08 Asan Labs., Ltd. Verwendung von Histondeacetylase-Hemmern zur Behandlung von gastrointestinaler Störungen
KR102735818B1 (ko) 2015-01-23 2024-11-28 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 암 예방에서 단쇄 지방산의 용도
WO2018052357A1 (en) * 2016-09-19 2018-03-22 Perstorp Ab A dietary supplement for alleviating chronic inflammation in colon
US11065217B2 (en) 2017-01-27 2021-07-20 Temple University—Of the Commonwealth System of Higher Education Use of short chain fatty acids for the treatment and prevention of diseases and disorders
AU2018255269B2 (en) 2017-04-17 2023-03-09 The University Of Chicago Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease
JP2020120603A (ja) * 2019-01-30 2020-08-13 株式会社明治 ケトン体産生促進用組成物
US11666548B2 (en) 2020-06-05 2023-06-06 Baxter International Inc. Parenteral nutrition formulation
US20220160669A1 (en) 2020-11-24 2022-05-26 Baxter International Inc. Parenteral nutrition formulation

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409239A (en) * 1982-01-21 1983-10-11 Syntex (U.S.A.) Inc. Propylene glycol diester solutions of PGE-type compounds
ATE24266T1 (de) * 1982-04-16 1987-01-15 Nestle Sa Lipidhaltige zusammensetzung fuer die orale, enterale oder parenterale ernaehrung.
US4528197A (en) * 1983-01-26 1985-07-09 Kabivitrum Ab Controlled triglyceride nutrition for hypercatabolic mammals
US4665057A (en) * 1983-03-22 1987-05-12 Deanna Nelson Nutrient monoesters
US4703062A (en) * 1984-01-16 1987-10-27 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US4678807A (en) * 1984-03-01 1987-07-07 Baxter Travenol Laboratories, Inc. Method for directed visceral metabolism of medium chain triglycerides
US4721716A (en) * 1984-08-06 1988-01-26 Neesby Torben E Method for desensitizing the gastrointestinal tract from food allergies
US4585764A (en) * 1985-04-22 1986-04-29 Sterling Drug Inc. Gastric cytoprotection with 3,3'-thiobis[propanoic acid] in oral administration of aspirin
US4735967A (en) * 1985-05-28 1988-04-05 Neesby Torben E Method for desensitizing the gastrointestinal tract from food allergies
US4690820A (en) * 1985-06-07 1987-09-01 The State University Of New York High-caloric, high-fat dietary formula
US4753963A (en) * 1985-09-26 1988-06-28 The Procter & Gamble Company Nutritional fat suitable for enteral and parenteral products
US4678808A (en) * 1985-10-15 1987-07-07 Baxter Travenol Laboratories, Inc. Rapid acting intravenous emulsions of omega-3 fatty acid esters
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US4810726A (en) * 1987-04-01 1989-03-07 New England Deaconess Hospital Corporation Kernel oils and disease treatment
US4952606A (en) * 1988-04-05 1990-08-28 New England Deaconess Hospital Corporation Structured lipid containing dairy fat
SE8803141L (sv) * 1988-09-07 1990-03-08 Kabivitrum Ab Naeringsmedel foer maenniskor och djur
US4992292A (en) * 1989-02-16 1991-02-12 Nabisco Brands, Inc. Tris-hydroxymethyl alkane dicarboxylate extended esters as low calorie fat mimetics
DE69016200T3 (de) * 1989-04-07 2000-01-13 New England Deaconess Hospital Corp., Boston Kurzkettige triglyceride.
DK657689D0 (da) * 1989-12-22 1989-12-22 Novo Nordisk As Middel med biologisk virkning paa tarmslimhinden

Also Published As

Publication number Publication date
DE69123278D1 (de) 1997-01-09
EP0451750A2 (de) 1991-10-16
EP0451750A3 (en) 1992-05-20
ES2097162T3 (es) 1997-04-01
EP0451750B1 (de) 1996-11-27
CA2039980A1 (en) 1991-10-11
AU645070B2 (en) 1994-01-06
AU7405091A (en) 1991-10-17
US5919822A (en) 1999-07-06
JPH05306222A (ja) 1993-11-19
DE69123278T2 (de) 1997-03-20

Similar Documents

Publication Publication Date Title
ATE145554T1 (de) Verwendung von kurzkettige fettsäuren enthaltenden lipiden zur aufrechterhaltung der integrität und der funktion des magen-darm-kanals
IL137848A0 (en) Indole-3-propionic acids, salts and esters thereof used as medicaments
ATE84414T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eines arneimittels zur behandlung von komplikationen bei diabetes mellitus.
AU1130988A (en) Thiazolidinone derivatives, their preparation and their use
FI883423A0 (fi) Foerfarande foer framstaellning av terapeutisk anvaendbara piperazinylderivat av puriner.
LU90949I2 (fr) Esters aminoalcohol d'acide thienylcarboxyliques leurs produits quaternaires leur préparation et l'utilisation de ces composés
GB2198135B (en) Derivatives of cyclohexane
IE882366L (en) Immunostimulant tripeptides
CA2072366A1 (en) Carboxylic acid-metal ion-acid complexes
ATE123944T1 (de) Verwendung von trifluormethylphenyl- tetrahydropyridinen zur herstellung von arzneimitteln zur behandlung anxio-depressiver erkrankungen.
WO1987004926A3 (en) Method of modifying the lipid structure of cell membranes and pharmaceutical compositions for use therein
GB8811423D0 (en) Alkenoic acid derivatives
DE69015910D1 (de) Pharmazeutische Verwendung von Fettsäuren.
DE3685275D1 (de) Herstellung von 5-fluor-2'-deoxyuridin estern zur intravenoesen verabreichung.
BR8801724A (pt) Artigo formado de uma composicao de pvc e processo para sua preparacao
MX9803565A (es) Metodo para inhibir la union de h, influenzae a celulas humanas utilizando beta-caseina humana, fosforilada, recombinante.
JPS649938A (en) Oral ingestive composition
PT84580A (en) Process for the preparation of pharmaceutical compositions containing indomethacin
EP0369776A3 (de) Verwendung einer Zusammensetzung, die organisch gebundenes Germanium enthaltet, zur Herstellung von Arzneimitteln zur Behandlung von AIDS
AU1158197A (en) Product for inhibition of attachment of h. influenzae to human cells
NZ329311A (en) use of beta-casein to inhibit infection in mammalian cells by respiratory syncytial virus
MX9605829A (es) Inhibicion de la union del h. influenzae a celulas humanas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties